chr4-88459398-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016323.4(HERC5):c.317C>A(p.Ala106Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000394 in 1,597,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016323.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HERC5 | NM_016323.4 | c.317C>A | p.Ala106Glu | missense_variant | 2/23 | ENST00000264350.8 | |
HERC5 | XM_011532022.3 | c.317C>A | p.Ala106Glu | missense_variant | 2/21 | ||
LOC102723458 | XR_938972.3 | n.19+8233G>T | intron_variant, non_coding_transcript_variant | ||||
LOC102723458 | XR_938976.3 | n.76+8233G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HERC5 | ENST00000264350.8 | c.317C>A | p.Ala106Glu | missense_variant | 2/23 | 1 | NM_016323.4 | P1 | |
HERC5 | ENST00000508695.1 | n.265C>A | non_coding_transcript_exon_variant | 2/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000698 AC: 17AN: 243494Hom.: 0 AF XY: 0.0000757 AC XY: 10AN XY: 132068
GnomAD4 exome AF: 0.0000367 AC: 53AN: 1445324Hom.: 0 Cov.: 27 AF XY: 0.0000459 AC XY: 33AN XY: 719410
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2023 | The c.317C>A (p.A106E) alteration is located in exon 2 (coding exon 2) of the HERC5 gene. This alteration results from a C to A substitution at nucleotide position 317, causing the alanine (A) at amino acid position 106 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at